Healthcare >> CEO Interviews >> January 26, 2004
DR. WILLIAM L. HUNTER is President and Chief Executive Officer of
Angiotech Pharmaceuticals, Inc. Dr. Hunter is a Founder and a member of
its scientific and management teams. He has co-authored many peer-
reviewed publications and abstracts, funded research grants and numerous
patents and patent applications since 1992. Dr. Hunter is active in the
Science Council of British Columbia and serves as a director of Vigil
Health Management Inc., The Michael Smith Foundation for Health Research
and as an Advisory Board member for the Biotechnology MBA Program at the
University of Western Ontario's Ivey School of Business. Dr. Hunter
received his BSc from McGill University, Montreal in 1985 and his MSc
and MD from the University of British Columbia in 1989 and 1992,
respectively. He has earned numerous awards including the 2002 BC
Biotech Vision and Leadership Award, the 2001 Pacific Region
Entrepreneur of the Year Award for Technology and Communications,
British Columbia Science and Technology Award for Industrial Innovation,
Business in Vancouver's Top 40 under 40, as well as the Caldwell
Partners Canada's Top 40 under 40. Profile
Pharmaceuticals?
Mr. Hunter: The premise of the company is really quite straightforward.
We use traditional pharmaceutical agents to
